Literature DB >> 9274831

Changes in the expression of novel Cdk5 activator messenger RNA (p39nck5ai mRNA) during rat brain development.

X H Cai1, K Tomizawa, D Tang, Y F Lu, A Moriwaki, M Tokuda, S Nagahata, O Hatase, H Matsui.   

Abstract

We previously reported that a neuron-specific Cdk5 activator, p35nck5ai, was most prominent in the newborn rat brain. In the adult brain, the expression decreased in most regions except hippocampus and primary olfactory cortex. A novel neuron-specific Cdk5 activator, p39nck5ai, has been recently cloned. To clarify whether two activators were differentially distributed throughout brain development, in this study, we examined the spatial and temporal expression of p39nck5ai in the development rat brain. Northern blot analysis showed that p39nck5ai expression was low in 15-day old fetuses and newborn, and was most prominent in the 1-3 week-old rat brains. In the adult rat brain, expression declined to the same level as in newborn rat brain. In situ hybridization showed that p39nck5ai mRNA was weakly expressed in all neurons of all regions in the newborn rat brain and the transcriptional level was highest in all regions in the 3 week-old rat brain. In the adult, expression was decreased in most neurons except Purkinje and granule cells in the cerebellum which retained high levels. These results suggest that p35nck5a and p39nck5ai may have different functional roles in distinct brain regions during different states of the rat brain development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274831     DOI: 10.1016/s0168-0102(97)00063-1

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  15 in total

Review 1.  Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD).

Authors:  June Bryan de la Peña; Irene Joy Dela Peña; Raly James Custodio; Chrislean Jun Botanas; Hee Jin Kim; Jae Hoon Cheong
Journal:  Mol Neurobiol       Date:  2017-05-22       Impact factor: 5.590

2.  Activity-dependent phosphorylation of neuronal Kv2.1 potassium channels by CDK5.

Authors:  Oscar Cerda; James S Trimmer
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

3.  Attention-deficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35.

Authors:  Justin M Drerup; Kanehiro Hayashi; Huxing Cui; Gabriel L Mettlach; Michael A Long; Marian Marvin; Xiankai Sun; Matthew S Goldberg; Michael Lutter; James A Bibb
Journal:  Biol Psychiatry       Date:  2010-09-15       Impact factor: 13.382

4.  p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment.

Authors:  J Ko; S Humbert; R T Bronson; S Takahashi; A B Kulkarni; E Li; L H Tsai
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

5.  Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth.

Authors:  G Paglini; G Pigino; P Kunda; G Morfini; R Maccioni; S Quiroga; A Ferreira; A Cáceres
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

6.  Loss of Cdk5 function in the nucleus accumbens decreases wheel running and may mediate age-related declines in voluntary physical activity.

Authors:  Gregory N Ruegsegger; Ryan G Toedebusch; Thomas E Childs; Kolter B Grigsby; Frank W Booth
Journal:  J Physiol       Date:  2016-09-15       Impact factor: 5.182

7.  Neuronal cyclin-dependent kinase 5 activity is critical for survival.

Authors:  T Tanaka; T Ohshima; P Rajan; N D Amin; A Cho; T Sreenath; H C Pant; R O Brady; A B Kulkarni
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

8.  Cdk5 modulates cocaine reward, motivation, and striatal neuron excitability.

Authors:  David R Benavides; Jennifer J Quinn; Ping Zhong; Ammar H Hawasli; Ralph J DiLeone; Janice W Kansy; Peter Olausson; Zhen Yan; Jane R Taylor; James A Bibb
Journal:  J Neurosci       Date:  2007-11-21       Impact factor: 6.167

9.  Cyclin-dependent kinase 5-deficient mice demonstrate novel developmental arrest in cerebral cortex.

Authors:  E C Gilmore; T Ohshima; A M Goffinet; A B Kulkarni; K Herrup
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

10.  Sp1 and Sp3 regulate transcription of the cyclin-dependent kinase 5 regulatory subunit 2 (p39) promoter in neuronal cells.

Authors:  Alvaro Valin; Julie D Cook; Sarah Ross; Christi L Saklad; Grace Gill
Journal:  Biochim Biophys Acta       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.